1887
Preview this article:

There is no abstract available.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.47259-0
2007-12-01
2024-04-20
Loading full text...

Full text loading...

/deliver/fulltext/jmm/56/12/1705.html?itemId=/content/journal/jmm/10.1099/jmm.0.47259-0&mimeType=html&fmt=ahah

References

  1. Bogdanovich T., Bozdogan B., Appelbaum P. C. 2006; Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae . Antimicrob Agents Chemother 50:893–898 [CrossRef]
    [Google Scholar]
  2. Bozdogan B., Appelbaum P. C. 2004; Macrolide resistance in streptococci and Haemophilus influenzae . Clin Lab Med 24:455–475 [CrossRef]
    [Google Scholar]
  3. CLSI 2006 Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically , approved standard M7–A7 Wayne, PA: Clinical and Laboratory Standards Institute;
    [Google Scholar]
  4. Hansen L. H., Mauvais P., Douthwaite S. 1999; The macrolide-ketolide antibiotic binding site is formed by structures in domains II and V of 23S ribosomal RNA. Mol Microbiol 31:623–631 [CrossRef]
    [Google Scholar]
  5. Peric M., Bozdogan B., Jacobs M. R., Appelbaum P. C. 2003; Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates. Antimicrob Agents Chemother 47:1017–1022 [CrossRef]
    [Google Scholar]
  6. Peric M., Bozdogan B., Galderisi C., Krissinger D., Rager T., Appelbaum P. C. 2004; Inability of L22 ribosomal protein alteration to increase macrolide MICs in the absence of efflux mechanism in Haemophilus influenzae HMC-S. J Antimicrob Chemother 54:393–400 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.47259-0
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error